Immunotherapy is how to process lower creatinine

After several clinical proof that the majority of patients have kidney disease will cause creatinine increased, because of the decline in kidney function, kidney affected by external factors, leading to glomerular damage to the toxic substances can not be normal filtration, while the tubular reabsorption would also fall, so the outflow of nutritious substances. Whole body metabolic disorders, mainly because of decreased immunity.
The human body is divided into two of the innate immune system and spare immune system, like the innate immune system is the "death squads", as long as the outside world there are toxic substances enter the body, the innate immune system will run ahead to clear the virus first. can not maintain normal body metabolic balance when the body's innate immune system damage can not be normal to remove the external harmful substances, that is, decreased immunity, it will enable a spare immune system means that the "reserve" the innate immune system and standby The immune system will be coordinated combat against the alien against viruses and bacteria. When the body back to normal, spare immune system will return to the relaxed state, the innate immune system to continue to fight off the virus. This is the normal state of immune function.
Dialysis is an alternative to kidney detoxification can be taken, when the body's innate immune system and spare immune system disorders can not maintain normal body metabolic balance, dialysis instead of kidney toxins by dialysis, but this therapy has no therapeutic role. Then immune therapy still need to have dialysis do?
The principle of immune therapy: a new anti-immune drugs suppress the immune response to stop kidney damage, immunotherapy repair, clear and protect the role of intrinsic cell by immunotherapy repair damage inherent in cells with impaired renal function returned to normal , clear immune complex deposition of the kidneys removed, and create favorable conditions for the recovery of renal function, the protection is no damage to the kidneys, the natural cell protection, to prevent its damage. Effective recovery of the kidneys of normal physiological functions.

What are the complications of Chronic renal failure

Chronic renal failure patients how to eat? Chronic renal failure patients how to eat? Chronic renal failure is a serious chronic kidney disease, not only do harm to the patient's physical and mental health, but also to the patient's daily life and work a great impact. Chronic renal failure patients live year-round drug separated from the mouth of the day, feel pain, so much trouble to his family. Not just rely on drugs for the treatment of chronic renal failure, should pay more attention to food and drink. Renal failure patients should be science diet, science diet plays a big role in the rehabilitation of chronic renal failure.
(A) the symptoms of nervous system
Nervous system symptoms are the main symptoms of chronic renal failure. Early in renal failure, patients often have dizziness, headache, fatigue, comprehension and memory loss and other symptoms. As the disease increased irritability, muscle trembling, convulsions; last may progress to a lack of facial expression, lethargy and coma. These symptoms occur with the following factors: ① certain toxic substances accumulation may cause degeneration of nerve cells; ② electrolyte and acid-base balance disorder; ③ renal hypertension due to cerebral vasospasm, hypoxia, and capillary permeability increased, which can cause brain cell degeneration and brain edema.
(B) symptoms of cardiovascular system
Chronic renal failure due to the role of renal hypertension, acidosis, hyperkalemia, sodium and water retention, anemia, and toxic substances, etc., can occur in heart failure, arrhythmias and myocardial damage. Stimulate the role of urea (and possibly acid), aseptic pericarditis can also occur in patients with heart chest pain; medical news and pericardial friction rub. Severe pericardial cavity, cellulose and bloody exudate appears.
(C) digestive symptoms
The earliest symptoms of the digestive system of patients with chronic renal failure is loss of appetite or indigestion; exacerbations, anorexia, nausea, vomiting or diarrhea. The occurrence of these symptoms may be associated with the bacteria in the gut urease decomposition of urea to ammonia, ammonia stimulation of the gastrointestinal mucosa caused by inflammation and multiple superficial ulcers. The patients are often complicated by gastrointestinal bleeding. In addition, nausea, vomiting, central nervous system dysfunction.

Why Diabetes Patients Have Coronary Heart Disease

Why do diabetes patients have coronary heart disease? The reasons are as follows:
1. Long time high blood pressure can lead fat into walls of blood vessels.
2. Diabetes patients usually have hyperlipemia, which can promote the occurrence of atherosclerosis.
3. The stability of sex hormone changes, which leads to high rate of heart disease.
4. In diabetes patients, the blood is in hypercoagulation status, thus causing thrombosis. In this condition, the micro-blood vessels are blocked and tissues are in the insufficiency of oxygen.
5. Many diabetes patients have high blood pressure, which will make heart work more give more burden to heart thus causing damage to the heart.
6. Many diabetes patients have obesity, which is also harmful to the heart for the fat will accumulate around heart.
7. Type 2 diabetes patients usually have hyperinsulinemia, which increases the dissolving fat ability of arteries and accelerate the course of arteriosclerosis.
8. In the early stage of diabetes, inner organ’s micro-blood vessels can be damaged, which leads to the damage of wall of arteries.

Why Metabolic Bone Disease in Chronic Kidney Disease

Metabolic bone disease is a common complication of chronic kidney disease (CKD) and is part of a broad spectrum of disorders of mineral metabolism that occur in this clinical setting and result in both skeletal and extraskeletal consequences. Detailed research in that past 4 decades has uncovered many of the mechanisms that are involved in the initiation and maintenance of the disturbances of bone and mineral metabolism and has been translated successfully from “bench to bedside” so that efficient therapeutic strategies now are available to control the complications of disturbed mineral metabolism. Recent emphasis is on the need to begin therapy early in the course of CKD. Central to the assessment of disturbances in bone and mineral metabolism is the ability to make an accurate assessment of the bone disease by noninvasive means. This remains somewhat problematic, and although measurements of parathyroid hormone are essential, recently recognized difficulties with these assays make it difficult to provide precise clinical practice guidelines for the various stages of CKD at the present time. Further research and progress in this area continue to evaluate the appropriate interventions to integrate therapies for both the skeletal and extraskeletal consequences with a view toward improving patient outcomes.

Metabolic bone disease is a common complication of chronic kidney disease (CKD) and is part of a broad spectrum of disorders of mineral metabolism that occur in this clinical setting. Alterations in the control mechanisms for calcium and phosphorus homeostasis occur early in the course of CKD and progress as kidney function decreases; if left untreated, then alterations can result in significant consequences. The disorders of bone have to be considered not only with regard to the bone itself but also with regard to the consequences of disturbed mineral metabolism at extraskeletal sites, including the vasculature. In recognition of the broad spectrum of disorders of mineral metabolism in this clinical setting, it has been recommended that terms such as “renal osteodystrophy” and “renal bone disease” give way to the term “CKD-mineral and bone disorder” to describe this broad clinical syndrome that develops as a systemic disorder of mineral and bone metabolism as a result of CKD that can be manifested by any one or a combination of the following: (1) Abnormalities of calcium, phosphorus, parathyroid hormone (PTH), and vitamin D metabolism; (2) abnormalities of bone turnover, mineralization, volume, linear growth, and strength; and vascular or soft tissue calcification .
The abnormalities in bone in the setting of CKD include the effects of high levels of PTH on bone, which results in the high-turnover bone disease osteitis fibrosa. In addition, in the setting of CKD, a different skeletal abnormality known as adynamic bone, which is characterized by an extremely low bone turnover, may occur. Some cases may demonstrate mineralization defects and show frank osteomalacia. This wide spectrum of skeletal abnormality can give rise to a variety of mixed patterns, with elements of the effects of hyperparathyroidism on bone together with mineralization defects, and is known as mixed renal osteodystrophy. In addition, other systemic processes that may affect the skeleton, such as the accumulation of β-2 microglobulin or the systemic effects of postmenopausal osteoporosis or steroid-induced osteoporosis, may complicate the picture. A wide variety of disturbances of bone metabolism may occur in the setting of CKD. An understanding of the pathogenesis of these abnormalities then becomes essential to design a rational approach to their treatment and to the prevention of complications.

Bone Disease in Chronic Kidney Disease

CKD-MBD occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood, leading to abnormal bone hormone levels. CKD-MBD is a common problem in people with kidney disease and affects almost all patients receiving dialysis.
CKD-MBD is most serious in children because their bones are still growing. The condition slows bone growth and causes deformities. One such deformity occurs when the legs bend inward toward each other or outward away from each other; this deformity is referred to as “renal rickets.” Another serious complication is short stature. Symptoms can be seen in growing children with renal disease even before they start dialysis.
In healthy adults, bone tissue is continually being remodeled and rebuilt. The kidneys play an important role in maintaining healthy bone mass and structure because one of their jobs is to balance calcium and phosphorus levels in the blood and ensure the vitamin D a person receives from sunlight and food becomes activated.
Calcium is a mineral that builds and strengthens bones. Calcium is found in many foods, particularly milk and other dairy products. If calcium levels in the blood become too low, four small glands in the neck called the parathyroid glands release a hormone called parathyroid hormone (PTH). This hormone draws calcium from the bones to raise blood calcium levels. Too much PTH in the blood will remove too much calcium from the bones; over time, the constant removal of calcium weakens the bones.
Phosphorus, an element found in most foods, also helps regulate calcium levels in the bones. Healthy kidneys remove excess phosphorus from the blood. When the kidneys stop working normally, phosphorus levels in the blood can become too high, leading to lower levels of calcium in the blood and resulting in higher PTH levels and the loss of calcium from the bones. Even before blood levels of phosphorus become elevated, the kidneys are forced to work harder to clear phosphorus from the body.
How is CKD-MBD treated?
CKD-MBD can be treated with changes in diet. Reducing dietary intake of phosphorus is one of the most important steps in preventing bone disease. Almost all foods contain phosphorus, but it is especially high in milk, cheese, dried beans, peas, nuts, and peanut butter. Drinks such as cocoa, dark sodas, and beer are also high in phosphorus. Often, medications called phosphate binders—such as calcium carbonate (Tums), calcium acetate (PhosLo), sevelamer hydrochloride (Renagel), or lanthanum carbonate (Fosrenol)—are prescribed with meals and snacks to bind phosphorus in the bowel. These medications decrease the absorption of phosphorus into the blood. A renal dietitian can help develop a dietary plan to control phosphorus levels in the blood.

What are the symptoms of renal cysts

The symptoms of renal cysts are benign, it was classified as renal cystic disease. Renal cystic disease, the symptoms of simple renal cysts are the most common. Incidence of more than 50 percent of the population over the age of 50. Is generally unilateral and single hair polarity by multiple or multiple, bilateral occurrence of rare. Unilateral and single kidney cyst symptoms are relatively harmless, and often overlooked clinically. Any age can occur, but more than 2/3 found in people aged over 60 is considered geriatric diseases. Kidney cyst from the renal parenchyma, prominent renal cortical surface, the appearance of the blue, but can also be located in the deep renal cortex or medulla. Wall thin, simple squamous epithelium, the sac containing clear serous fluid. The capsule wall thickness and smooth liquid to bloody, suggesting the possibility of malignancy, the malignancy rate of 3% to 7%. Located under a huge renal cysts, may compress the ureter causing obstruction, effusion, and infection. The causes of kidney cysts is not fully understood, the infection may be associated with congenital glomerular and tubular structural anomalies and acquired injury.
The symptoms of renal cysts is a traditional Chinese medicine Zhengjia areas.Dystrophy, congenital or acquired kidney damage, collaterals and induced renal capsule bloody cohesive visceral sac-like illness.
Symptoms of polycystic kidney disease and renal cysts (multiple renal cysts) is not a disease. Medical Division is too small, the disease is so much variety, indeed a considerable number of people this mix of both diseases. It should be said is not difficult to distinguish between the two:
Kidney cyst etiology and pathogenesis: the symptoms of renal cysts is often dyed genetic disease, multiple renal cysts can be congenital (embryonic form), but caused by traumatic, inflammatory, and tumor.
Family history: polycystic kidney disease family members with similar patients with similar patients often have no symptoms of multiple renal cysts in patients with family.
Capsule contents: polycystic kidney urine, multiple kidney cyst fluids (like plasma) containing red blood cells.

Symptoms of renal cysts

① waist, abdominal discomfort or pain: The reason is that the tension increases due to kidney enlargement and expansion of the renal capsule, the renal pedicle by traction, or to adjacent organs caused by compression. In addition, kidney polycystic kidney water content, become heavy, falling traction will cause lower back pain. The pain is characterized by pain, dull, fixed in one or both down, waist back radiation. If intracystic bleeding or secondary infection, make the pain flare. Such as the merger of the stones or bleeding blood clots blocking the urinary tract, can renal colic.
② hematuria: microscopic hematuria or gross hematuria. The onset of cyclical. Attack of low back pain, often exacerbated by strenuous exercise, trauma, infection can be induced or aggravated. The causes of bleeding because of the wall below the number of arterial pressure to increase co-infection, so that the wall of blood vessel rupture due to excessive traction.
③ abdominal mass: sometimes as the main reason for patient visits, 60% to 80% of patients with palpable enlargement of the kidney. In general, the greater the kidney, the renal function was worse.
④ proteinuria: small, 24-hour urine does not exceed 2g. Multi-does not occur with nephrotic syndrome.
⑤ hypertension: Solid cyst oppression kidney, causing renal ischemia, so that the increase in renin secretion caused by high blood pressure. With normal renal function, more than 50% of patients with hypertension, renal dysfunction, higher incidence of hypertension.
⑥ renal insufficiency: due to the cystic space-occupying, oppression, and normal kidney tissue was significantly decreased.